title: Does prophylactic breast irradiation in patients with prostate cancer influence cardiac toxicity?
authors.forename: Carsten
authors.initials: C
authors.lastname: Nieder
authors.forename: Adam
authors.initials: A
authors.lastname: Pawinski
authors.forename: Nicolaus H
authors.initials: NH
authors.lastname: Andratschke
authors.forename: Michael
authors.initials: M
authors.lastname: Molls
mesh_terms: D000368:Aged; D000726:Androgen Antagonists / Q000008:administration & dosage / Q000009:adverse effects*; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D004730:Endothelium, Vascular / Q000528:radiation effects; D006177:Gynecomastia / Q000139:chemically induced / Q000517:prevention & control* / Q000532:radiotherapy*; D006321:Heart / Q000528:radiation effects*; D006801:Humans; D008297:Male; D011471:Prostatic Neoplasms / Q000188:drug therapy*; D011878:Radiotherapy / Q000009:adverse effects; D011879:Radiotherapy Dosage; D014057:Tomography, X-Ray Computed
chemical_list: D000726:Androgen Antagonists; D000970:Antineoplastic Agents